U.S. FDA approves first treatment option for generalized pustular psoriasis flares in adults
Press release content from Business Wire. The AP news staff was not involved in its creation.
Source: apnews.com
Page 20 - Human Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Human Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Human Pharma Today - Breaking & Trending Today
FDA approves the first treatment option for generalized pustular psoriasis flares in adults
More than half of patients treated with SPEVIGO® (spesolimab-sbzo) injection, for intravenous use showed no visible pustules one week after receiv...
Source: businessinsider.com
Boehringer Ingelheim: U.S. FDA approves first treatment option for generalized pustular psoriasis flares in adults
Spesolimab is a monoclonal antibody that inhibits interleukin-36 (IL-36) signaling and is the first treatment specifically approved for the treatment of generalized pustular psoriasis flares After
Source: finanznachrichten.de
FDA approves the first treatment option for generalized pustular psoriasis flares in adults
/PRNewswire/ -- Boehringer Ingelheim announced today the U.S. Food and Drug Administration has approved SPEVIGO, the first approved treatment option for...
Source: prnewswire.com
FDA approves the first treatment option for generalized pustular psoriasis flares in adults
/PRNewswire/ -- Boehringer Ingelheim announced today the U.S. Food and Drug Administration has approved SPEVIGO, the first approved treatment option for...
Source: prnewswire.com